Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Avalo Therapeutics (AVTX) Other Gross PP&E Adjustments (2016 - 2025)

Avalo Therapeutics' Other Gross PP&E Adjustments history spans 12 years, with the latest figure at -$100000.0 for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 113.85% year-over-year to -$100000.0; the TTM value through Dec 2025 reached -$100000.0, down 113.85%, while the annual FY2025 figure was -$100000.0, 113.85% down from the prior year.
  • Other Gross PP&E Adjustments reached -$100000.0 in Q4 2025 per AVTX's latest filing, up from -$402000.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $722000.0 in Q4 2024 to a low of -$1.9 million in Q1 2022.
  • Average Other Gross PP&E Adjustments over 5 years is -$755200.0, with a median of -$809500.0 recorded in 2021.
  • Peak YoY movement for Other Gross PP&E Adjustments: crashed 159.74% in 2022, then soared 64.71% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $587000.0 in 2021, then decreased by 0.85% to $582000.0 in 2022, then increased by 23.37% to $718000.0 in 2023, then rose by 0.56% to $722000.0 in 2024, then crashed by 113.85% to -$100000.0 in 2025.
  • Per Business Quant, the three most recent readings for AVTX's Other Gross PP&E Adjustments are -$100000.0 (Q4 2025), -$402000.0 (Q3 2025), and -$487000.0 (Q2 2025).